Below are just some of the comments we have received from our clients, about the services we have provided for them.

Strategic oversight of NICE Multiple Technology Appraisal, Ipsen Biopharm
  • Region: UK
  • Date: July 2016

Therapy Area: Spasticity post stroke

Read more…

Develop a Diabetes Evaluation Tool for NHS, Novo Nordisk UK
  • Region: UK
  • Date: April 2015

Therapy Area: Diabetes (type 2)

Read more…

HTA dossier for medical device reviewed by MSAC, Aurora BioScience Pty Ltd
  • Region: Australia
  • Date: February 2015

Therapy Area: Epilepsy (treatment resistant)

Read more…

Commercial Strategy across global portfolio, ViiV Healthcare
  • Region: Global
  • Date: March 2011

Therapy Area: HIV and AIDS

Read more…

Reimbursement and Access projects for UK, Allergan Health
  • Region: UK
  • Date: December 2009

Therapy Area: Bariatric market (obesity)

Read more…

SMC and AWMSG HTA submissions, Celgene UK & Ireland
  • Region: UK
  • Date: January 2009

Therapy Area: Multiple myeloma

Read more…

Two SMC submissions. Interactive model in NHS, LEO Pharma UK
  • Region: UK
  • Date: December 2007

Therapy Area: Body psoriasis; scalp psoriasis

Read more…

Strategice input as inhouse consultant. SMC submission, Pricing & Reimbursement, O’Bryan-Tear Consulting Ltd
  • Region: UK and EU
  • Date: November 2007

Therapy Area: Diabetes (type 2) and transplantation

Read more…

Inhouse strategic health economic consultancy, Cambridge Antibody Technology
  • Region: EU and USA
  • Date: January 2005

Therapy Area: Ophthalmology (glaucoma)

Read more…

Interactive market access tool, Bristol-Myers Squibb
  • Region: UK
  • Date: August 2002

Therapy Area: Schizophrenia

Read more…